Viewing StudyNCT05799287



Ignite Creation Date: 2024-05-06 @ 6:49 PM
Last Modification Date: 2025-12-17 @ 5:31 PM
Study NCT ID: NCT05799287
Status: None
Last Update Posted: 2025-10-03 00:00:00
First Post: 2023-03-05 00:00:00

Brief Title: A Study of Telitacicept in Patients With Primary Immunoglobulin A(IgA) Nephropathy
Sponsor: RemeGen Co Ltd
Organization: RemeGen Co., Ltd.

Organization Data

Organization: RemeGen Co., Ltd.
Class: INDUSTRY
Study ID: 18C021
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: RemeGen Co Ltd
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators